TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $15.38M2009: $6.90M2010: $20.35M2011: $10.90M2012: $48.85M2013: -$19.99M2014: $41.35M2015: $43.00M2016: -$32.48M2017: $208.37M2018: $248.89M2019: $91.77M2020: $151.05M2021: $196.95M2022: $169.80M2023: $83.81M2024: $363.82M2025: $48.81M$48.81M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$48.81M-86.6%
2024$363.82M+334.1%
2023$83.81M-50.6%
2022$169.80M-13.8%
2021$196.95M+30.4%
2020$151.05M+64.6%
2019$91.77M-63.1%
2018$248.89M+19.4%
2017$208.37M+741.5%
2016-$32.48M-175.5%
2015$43.00M+4.0%
2014$41.35M+306.9%
2013-$19.99M-140.9%
2012$48.85M+348.2%
2011$10.90M-46.4%
2010$20.35M+194.8%
2009$6.90M-55.1%
2008$15.38M—